APhA releases pharmacy management guide
WASHINGTON — The American Pharmacists Association has released a new information resource for pharmacists and pharmacy students about pharmacy management, the group said.
The APhA announced Wednesday the release of "Getting Started as a Pharmacy Manager," a 171-page book for new and aspiring pharmacy managers about handling such managing issues as managing people, adhering to laws and regulations, and running a business.
The book was written by American Association of Colleges of Pharmacy director of professional alliance development Lynette Bradley-Baker. It is available from the APhA’s website for $31.50, or $25 for organization members.
The APhA also announced the publication of the 17th edition of its guide to non-prescription drugs, "Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care." The new edition, which sells for $179.95, or $144 for APhA members, has a new chapter that focuses on self-care of diabetes and other disorders and two new appendices that cover safe use of non-prescription drugs, supplements and natural products during pregnancy, as well as vaccine information.
Election analyst, professor Larry Sabato to address 2012 NACDS Annual Meeting
ALEXANDRIA, Va. — The National Association of Chain Drug Stores has announced that election analyst and University of Virginia professor Larry Sabato will address attendees at the 2012 NACDS Annual Meeting on April 21 to 24 in Palm Beach, Fla.
Sabato will offer remarks to NACDS Annual Meeting attendees during the business program on Sunday, April 22.
“During this presidential and congressional election year, it is only fitting to have Larry Sabato address the attendees of the NACDS Annual Meeting,” NACDS president and CEO Steve Anderson said. “Larry’s astute election forecasting and political analyses are really second to none. We look forward to hearing his insights and predictions for the upcoming political season.”
Sabato is the founder and head of the University of Virginia’s Center for Politics, and is the author of more than 20 book and numerous essays on politics. He also spearheads “Sabato’s Crystal Ball,” a website providing detailed and updated analysis for elections nationwide. Sabato has received multiple awards and accolades including UVA’s highest honor, the Thomas Jefferson Award, has been a guest scholar at the Brookings Institution, Oxford University and Cambridge University.
He also has served on many national and state commissions, including the National Commission for the Renewal of American Democracy and the Senate Campaign Finance Reform Panel. Sabato has appeared on various news programs and is a regular contributor to National Public Radio.
FDA approves Actavis ADHD drug
MORRISTOWN, N.J. — The Food and Drug Administration has approved a generic version of a drug for attention deficit hyperactivity disorder made by Actavis, the drug maker said Wednesday.
Actavis announced the FDA approval of methylphenidate hydrochloride extended-release capsules in the 20-mg, 30-mg and 40-mg strengths, a generic version of Novartis’s Ritalin LA. Actavis said it was the first to file for regulatory approval of the drug in those three strengths, thus entitling it to 180 days of market exclusivity in which it will directly compete with the branded version.
The drug had sales of $80.7 million during the 12-month period ended in September, according to IMS Health.